Table 3.
Unadjusted and adjusted models for HPV vaccine knowledge score and HPV vaccine initiation (n = 77)
| HPV vaccine knowledge | HPV vaccine initiation | |||
|---|---|---|---|---|
| Unadjusted B [95% CI] | Adjusted B [95% CI] | Unadjusted OR [95% CI] | Adjusted OR [95% CI] | |
| Parent Characteristics | ||||
| Nativity | ||||
| Non-U.S. Born | −2.0 [−3.3, −0.7] | −1.7 [− 3.1, − 0.4] | 0.4 [0.1, 1.0] | 0.3 [0.1, 0.9] |
| U.S.-Born | Reference | Reference | Reference | Reference |
| Age (years) | ||||
| 30–40 | Reference | Reference | – | – |
| 41–50 | 1.3 [−0.4, 3.0] | 0.8 [−1.3, 2.8] | – | – |
| > 50 | 2.0 [0.1, 4.0] | 1.5 [−0.7, 3.7] | – | – |
| HPV Vaccine Knowledge | – | – | 1.3 [1.1, 1.5] | 1.3 [1.0, 1.7] |
| Adolescent Characteristics | ||||
| Age (years) | ||||
| 11–12 | 0.2 [−1.6, 2.0] | 0.5 [− 1.2, 2.2] | 0.02 [0.003, 0.2] | 0.01 [0.002, 0.2] |
| 13–15 | −1.0 [−2.5, 0.5] | −0.5 [−2.0, 1.0] | 0.3 [0.1, 1.0] | 0.4 [0.1, 1.6] |
| 16–18 | Reference | Reference | Reference | Reference |
| Gender | ||||
| Male | – | 0.3 [0.1, 0.9] | 0.1 [0.0, 0.6] | |
| Female | – | Reference | ||
| Insurance Type | ||||
| Private | Reference | Reference | – | – |
| Medicaid/CHIP | −0.5 [−2.3, 1.3] | −0.2 [−2.3, 2.0] | – | – |
| Uninsured/Other | −3.5 [−5.9, −1.1] | −2.3 [−4.9, 0.4] | – | – |
| Received Other Adolescent Vaccines | ||||
| Yes | – | – | 3.8 [1.4, 10.1] | 3.4 [0.9, 13.2] |
| No | – | – | Reference | Reference |
“–” indicates variable excluded from final model
HPV Human papillomavirus vaccine, OR Odds ratio, CI Confidence interval, CHIP Children’s Health Insurance Program, Tdap Tetanus, diphtheria, and acellular pertussis